ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
type: MedicalStudy
description: ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
status: RECRUITING
study design: OBSERVATIONAL
start date: 2020-11-23
end date: 2030-09-01
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT04561518
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Alnylam Pharmaceuticals
study subject: Transthyretin-Mediated Amyloidosis
study subject: ATTR Amyloidosis
keywords: OBSERVATIONAL
keywords: RECRUITING
keywords: Transthyretin-Mediated Amyloidosis
keywords: ATTR Amyloidosis

AI Analytics
type: Organization